Cargando…

Investigating endogenous µ-opioid receptors in human keratinocytes as pharmacological targets using novel fluorescent ligand

Opioids in skin function during stress response, regeneration, ageing and, particularly in regulating sensation. In chronic pruritus, topical treatment with Naltrexone changes μ-opioid receptor (μ-OR) localization to relieve itch. The molecular mechanisms behind the effects of Naltrexone on μ-OR fun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leong, Cheryl, Neumann, Christine, Ramasamy, Srinivas, Rout, Bhimsen, Yi Wee, Lim, Bigliardi-Qi, Mei, Bigliardi, Paul L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718609/ https://www.ncbi.nlm.nih.gov/pubmed/29211767 http://dx.doi.org/10.1371/journal.pone.0188607

Ejemplares similares

Specific Targeting of Melanotic Cells with Peptide Ligated Photosensitizers for Photodynamic Therapy
por: Bigliardi, Paul Lorenz, et al.
Publicado: (2017)

Activation of the δ-opioid receptor promotes cutaneous wound healing by affecting keratinocyte intercellular adhesion and migration
por: Bigliardi, P L, et al.
Publicado: (2015)

The δ-Opioid Receptor Affects Epidermal Homeostasis via ERK-Dependent Inhibition of Transcription Factor POU2F3
por: Neumann, Christine, et al.
Publicado: (2015)

Microbiome in the hair follicle of androgenetic alopecia patients
por: Ho, Bryan Siu-Yin, et al.
Publicado: (2019)

Progressive expression of PPARGC1α is associated with hair miniaturization in androgenetic alopecia
por: Ho, Bryan Siu-Yin, et al.
Publicado: (2019)

Pharmacological Profiles of Oligomerized μ-Opioid Receptors
por: Lee, Cynthia Wei-Sheng, et al.
Publicado: (2013)

Pharmacological profiles of opioid ligands at Kappa opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2006)

Evaluation of the applicability of the Immuno-solid-phase allergen chip (ISAC) assay in atopic patients in Singapore
por: Santosa, Amelia, et al.
Publicado: (2015)

2742. The Prevalence and Clinical Impact of Antibiotic Allergy Labels in Solid Organ Transplant Recipients
por: Nair, Sashi, et al.
Publicado: (2023)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

Conformational dynamics of the μ-opioid receptor determine ligand intrinsic efficacy
por: Zhao, Jiawei, et al.
Publicado: (2023)

Protein recognition by bivalent, ‘turn-on’ fluorescent molecular probes
por: Unger-Angel, Linor, et al.
Publicado: (2015)

Activation of endogenous opioid gene expression in human keratinocytes and fibroblasts by pulsed radiofrequency energy fields
por: Moffett, John, et al.
Publicado: (2012)

Low Molecular Weight Hyaluronic Acid (500–730 Kda) Injections in Tendinopathies—A Narrative Review
por: Frizziero, Antonio, et al.
Publicado: (2021)

A Miniaturized Therapeutic Chromophore for Multiple Metal Pollutant Sensing, Pathological Metal Diagnosis and Logical Computing
por: Rout, Bhimsen
Publicado: (2016)

Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
por: Morse, Megan, et al.
Publicado: (2013)

Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands
por: Sturaro, Chiara, et al.
Publicado: (2022)

Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system
por: Jassar, Hassan, et al.
Publicado: (2019)

Functional independence of endogenous μ- and δ-opioid receptors co-expressed in cholinergic interneurons
por: Arttamangkul, Seksiri, et al.
Publicado: (2021)

The interleukin 1 (IL-1) system in the uteroplacental complex of a cartilaginous fish, the smoothhound shark, Mustelus canis
por: Cateni, Chiara, et al.
Publicado: (2003)

CRISPR/Cas9 unveils the dynamics of the endogenous µ‐opioid receptors on neuronal cells under continuous opioid stimulation
por: Shimizu, Satoshi, et al.
Publicado: (2022)

Delineating the Ligand–Receptor Interactions That Lead to Biased Signaling at the μ-Opioid Receptor
por: Kelly, Brendan, et al.
Publicado: (2021)

A ligand-based 3D pharmacophore model for the μ opioid receptor: application to the morphinan class of opioids
por: Asim, Muhammad Faheem, et al.
Publicado: (2010)

Pharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation
por: Floettmann, Eike, et al.
Publicado: (2017)

Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013)

Efficacy of Core Stability in Non-Specific Chronic Low Back Pain
por: Frizziero, Antonio, et al.
Publicado: (2021)

Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone
por: Michaelides, Michael, et al.
Publicado: (2023)

Visualizing endogenous opioid receptors in living neurons using ligand-directed chemistry
por: Arttamangkul, Seksiri, et al.
Publicado: (2019)

N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists
por: Dumitrascuta, Maria, et al.
Publicado: (2020)

Sex Determination in Immature Sierra Nevada Lizard (Timon nevadensis)
por: Vetere, Alessandro, et al.
Publicado: (2022)

Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities
por: Schmidhammer, Helmut, et al.
Publicado: (2020)

Pharmacologic effects of naldemedine, a peripherally acting μ‐opioid receptor antagonist, in in vitro and in vivo models of opioid‐induced constipation
por: Kanemasa, Toshiyuki, et al.
Publicado: (2019)

Synthesis, Radiosynthesis and Biological Evaluation of Buprenorphine‐Derived Phenylazocarboxamides as Novel μ‐Opioid Receptor Ligands
por: Krüll, Jasmin, et al.
Publicado: (2020)

Toward a Universal μ-Agonist Template for Template-Based Alignment Modeling of Opioid Ligands
por: Wu, Zhijun, et al.
Publicado: (2019)

The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6
por: Moustafa, Shatha Rouf, et al.
Publicado: (2020)

Potential role of interleukin-1 at the peri-ovulation stage in a species of placental viviparous reptile, the three-toed skink, Chalcides chalcides (squamata: scincidae)
por: Romagnoli, Roberta, et al.
Publicado: (2003)

Working Remotely During the COVID-19 Pandemic: Work-Related Psychosocial Factors, Work Satisfaction, and Job Performance Among Russian Employees
por: Toscano, Ferdinando, et al.
Publicado: (2022)

Endogenous μ-opioid—Neuropeptide Y Y1 receptor synergy silences chronic postoperative pain in mice
por: Nelson, Tyler S, et al.
Publicado: (2023)

Effects of N-Substitutions on the Tetrahydroquinoline (THQ) Core of Mixed-Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) Ligands
por: Harland, Aubrie A., et al.
Publicado: (2016)

Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors
por: Puls, Kristina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nmr72f9cus62o1vleb62d7877h